Dienogest
- Generic Name
- Dienogest
- Brand Names
- Natazia, Visanne
- Drug Type
- Small Molecule
- Chemical Formula
- C20H25NO2
- CAS Number
- 65928-58-7
- Unique Ingredient Identifier
- 46M3EV8HHE
- Background
Dienogest is an orally-active semisynthetic progestogen which also possesses the properties of 17α-hydroxyprogesterone. It is a derivative of 19-nortestosterone and has antiandrogenic properties. It is primarily used as a contraceptive in combination with ethinylestradiol, or in other combination form pills approved in United States and Europe however it is ...
- Indication
Indicated for use as the treatment of endometriosis alone and as a contraceptive in combination with ethinylestradiol.
- Associated Conditions
- Hypermenorrhea, Pain
- Associated Therapies
- Contraception, Oral Contraceptives
Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery
- First Posted Date
- 2023-11-24
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Universitas Diponegoro
- Target Recruit Count
- 80
- Registration Number
- NCT06145438
- Locations
- 🇮🇩
Kariadi Hospital, Semarang, Central Java, Indonesia
Dienogest in Perimenopausal Women With Adenomyosis
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- National Taiwan University Hospital
- Target Recruit Count
- 87
- Registration Number
- NCT05751876
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
Comparisons of the Therapeutic Effects of Dienogest and Danazol on Endometriosis
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Far Eastern Memorial Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05697471
- Locations
- 🇨🇳
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao, New Taipei, Taiwan
Effect of Management of the Endometrioma on Ovarian Reserve
- Conditions
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- University of Valencia
- Target Recruit Count
- 100
- Registration Number
- NCT05637073
- Locations
- 🇵🇱
University Hospital Poznan, Poznan, Poland
🇪🇸Hosp Clinico Universitario-INCLIVA, Valencia, Spain
The Effect of Dionegest Use on the Frequency of Fibromyalgia in Endometriosis
- Conditions
- First Posted Date
- 2022-03-10
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Gaziosmanpasa Research and Education Hospital
- Target Recruit Count
- 61
- Registration Number
- NCT05272930
- Locations
- 🇹🇷
Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey
Goserline Acetate VS Dienogest in Endometriosi
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2021-10-20
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 40
- Registration Number
- NCT05013242
- Locations
- 🇪🇬
Mansoura University, Mansoura, الدقهلية, Egypt
Role of Suppression of Endometriosis With Progestins Before IVF-ET
- Conditions
- Interventions
- First Posted Date
- 2020-08-05
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- National Research Centre, Egypt
- Target Recruit Count
- 134
- Registration Number
- NCT04500743
- Locations
- 🇪🇬
Minia Infertility research unit, Minya, Egypt
Effects of Sulawesi Propolis Extract on Lesion Growth, Apoptotic and Inflammatory Activity of the Rat Endometriosis Tissue
- Conditions
- Interventions
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Indonesia University
- Target Recruit Count
- 120
- Registration Number
- NCT04374006
- Locations
- 🇮🇩
Animal Laboratory of Indonesia University, Jakarta, Capital Special Region, Indonesia
Comparison of the Operation and Medical Treatment of Endometriosis and Adenomyosis
- Conditions
- Interventions
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- Taipei Veterans General Hospital, Taiwan
- Target Recruit Count
- 5000
- Registration Number
- NCT03778359
- Locations
- 🇨🇳
Peng-Hui Wang, Taipei county, Taipei, Taiwan
Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 100
- Registration Number
- NCT03654144
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.